Author(s):
Desale Avishkar Kishor, Sonawane Mitesh P.
Email(s):
avidesale332004@gmail.com
DOI:
10.52711/0975-4377.2026.00013 
Address:
Desale Avishkar Kishor1*, Sonawane Mitesh P.2
1Student, Loknete Dr J.D. Pawar College of Pharmacy, Manur, Kalwan, Nashik - 423501, Maharashtra, Nashik, India.
2Vice Principal, Loknete Dr J.D. Pawar College of Pharmacy Manur, Kalwan, Nashik - 423501, Maharashtra, Nashik, India.
*Corresponding Author
Published In:
Volume - 18,
Issue - 1,
Year - 2026
ABSTRACT:
Artificial intelligence (AI) is reshaping healthcare and personalized medicine, particularly in the pharmaceutical industry. This review provides a comprehensive examination of current AI applications across various stages of the drug development pipeline, including drug discovery, clinical trial design, patient stratification, diagnosis, and treatment personalization. By employing advanced computational approaches such as machine learning, deep learning, and natural language processing, AI enables the integration and analysis of large and complex biological and clinical datasets, including genomic, proteomic, and electronic health record data. These capabilities facilitate the identification of novel therapeutic targets and support the development of individualized treatment strategies. The review also addresses critical considerations such as data quality, algorithmic transparency, ethical challenges, and regulatory frameworks that influence the safe and effective deployment of AI technologies. Furthermore, it highlights the growing need for robust data integration, interpretation strategies, and interdisciplinary collaboration to fully realize AI’s potential in advancing personalized medicine. Future perspectives emphasize AI’s role as a transformative tool for innovation in patient-centered pharmaceutical care.
Cite this article:
Desale Avishkar Kishor, Sonawane Mitesh P.. AI in Patient Care and Personalized Medicine in Pharmaceutical Industries. Research Journal of Pharmaceutical Dosage Forms and Technology.2026; 18(1):77-2. doi: 10.52711/0975-4377.2026.00013
Cite(Electronic):
Desale Avishkar Kishor, Sonawane Mitesh P.. AI in Patient Care and Personalized Medicine in Pharmaceutical Industries. Research Journal of Pharmaceutical Dosage Forms and Technology.2026; 18(1):77-2. doi: 10.52711/0975-4377.2026.00013 Available on: https://www.rjpdft.com/AbstractView.aspx?PID=2026-18-1-13
9. REFERENCES:
1. Raza MA. Artificial Intelligence (AI) in Pharmacy: An Overview. Pharmacy Practice. 2022; 20(1): e9836757
2. Khan O. The future of pharmacy: How AI is revolutionizing the industry. Science Direct. 2023.
3. Hasan HE. Ethical considerations and concerns in the implementation of AI in pharmacy. Pharmacy Practice. 2024; 22(1): e11096093.
4. Serrano DR. Artificial Intelligence (AI) Applications in Drug Discovery. Pharmacy Practice.2024; 22(2): e11510778.
5. Allam H. Prescribing the Future: The Role of Artificial Intelligence in Pharmacy. MDPI Information.2025;16(2):131.
6. Raza MA. Artificial Intelligence (AI) in Pharmacy: An Overview. Pharmacy Practice. 2022; 20(1): e9836757.
7. Personalized Treatment Plans. International Journal of Scientific Research and Technology.2025;11(3): e392364537.
8. Nagalakshmi R. Enhancing drug discovery and patient care through AI. ScienceDirect. 2025.
9. Roosan D. Effectiveness of ChatGPT in clinical pharmacy and the role of AI in patient interactions. JAm Pharm Assoc. 2024;64(5):e1003849
10. Farhud DD. Ethical Issues of Artificial Intelligence in Medicine and Pharmacy. Pharmacy Practice. 2021; 19(1): e8826344.
11. Johnson KB, et al. Precision Medicine, AI, and the Future of Personalized Healthcare. J Transl Med. 2021; 19(1): 1. doi: 10.1186/s12967-021-02778-6.
12. Parekh AE, et al. Artificial intelligence (AI) in personalized medicine: AI-generated personalized therapy regimens based on genetic and medical history. Ann Med Surg (Lond). 2023; 85:5831-5833. doi:10.1097/MS9.0000000000001320.
13. Schork NJ. Artificial Intelligence and Personalized Medicine. Pharmacogenomics. 2019; 20(3): 159170. doi: 10.2217/pgs-2018-0276.
14. Khan O, Badhiwala JH, Wilson JRF, Jiang F, Martin AR, Fehlings MG. Predictive Modeling of outcomes After Traumatic and Nontraumatic Spinal Cord Injury Using Machine Learning: Review of Current Progress and Future Directions. Neurospine. 2019; 16(4): 678-685.
15. Gill SS, Ponniah H, Giersztein S, Miriyala R, Namireddy SR, Killilea J, et al. The diagnostic and prognostic capability of artificial intelligence in spinal cord injury: A systematic review. Brain Spine. 2025; 5:104208.
16. An Q, Wang L, Zhang Q, et al. A Comprehensive Review on Machine Learning in Personalized Medicine: Application, Challenges and Future Prospects. Front Genet. 2023; 14: 123456. (Review)
17. Albahra S, Yigitkanli K, Kocak A. Artificial Intelligence and Machine Learning Overview in Medicine. Clin Lab Med. 2023; 43(1): 1-24.
18. Doroudi S, Baxter G. The Bias-Variance Tradeoff: How Data Science Can Inform Education Policy.AERA Open. 2020; 6(1): 2332858420977200.
19. Belkin M, Hsu D, Ma S, Mandal S. Reconciling modern machine learning practice and the biasvariance trade-off. arXiv preprint. 2018.
20. Rajkomar A, Dean J, Kohane I. Machine Learning in Medicine. N Engl J Med. 2019; 380(14): 13471358. doi:10.1056/NEJMra1814259 [21] Zhang X, et al.
21. Xu Y, et al Ethical considerations and concerns in the implementation of AI in pharmacy.
22. Miotto R, Li L, Kidd BA, Dudley JT. Deep Patient: An Unsupervised Representation to Predict the Future of Patients from the Electronic Health Records. Sci Rep. 2016; 6: 26094. doi:10.1038/srep26094
23. .Holzinger A, Biemann C, Pattichis CS, Kell DB. What do we need to build explainable AI systems for the medical domain? arXiv. 2017 Dec 28; 1712.09923. doi:10.48550/arXiv.1712.09923